[HTML][HTML] An advanced comprehensive muti-cell-type-specific model for predicting anti-PD-1 therapeutic effect in melanoma
W Sun, Y Zhu, Z Zou, L Wang, J Zhong, K Shen… - Theranostics, 2024 - ncbi.nlm.nih.gov
Rationale: Immune checkpoint inhibitors targeting the programmed cell death (PD)-1/PD-L1
pathway have promise in patients with advanced melanoma. However, drug resistance …
pathway have promise in patients with advanced melanoma. However, drug resistance …
An advanced comprehensive muti-cell-type-specific model for predicting anti-PD-1 therapeutic effect in melanoma
W Sun, Y Zhu, Z Zou, L Wang, J Zhong… - …, 2024 - pubmed.ncbi.nlm.nih.gov
Rationale: Immune checkpoint inhibitors targeting the programmed cell death (PD)-1/PD-L1
pathway have promise in patients with advanced melanoma. However, drug resistance …
pathway have promise in patients with advanced melanoma. However, drug resistance …
An advanced comprehensive muti-cell-type-specific model for predicting anti-PD-1 therapeutic effect in melanoma.
W Sun, Y Zhu, Z Zou, L Wang, J Zhong, K Shen, X Lin… - Theranostics, 2024 - europepmc.org
Rationale: Immune checkpoint inhibitors targeting the programmed cell death (PD)-1/PD-L1
pathway have promise in patients with advanced melanoma. However, drug resistance …
pathway have promise in patients with advanced melanoma. However, drug resistance …
[引用][C] An advanced comprehensive muti-cell-type-specific model for predicting anti-PD-1 therapeutic effect in melanoma
W Sun, Y Zhu, Z Zou, L Wang, J Zhong, K Shen, X Lin… - europepmc.org
Rationale: Immune checkpoint inhibitors targeting the programmed cell death (PD)-1/PD-L1
pathway have promise in patients with advanced melanoma. However, drug resistance …
pathway have promise in patients with advanced melanoma. However, drug resistance …